TB-500 Detection Time: What LC-MS Studies Actually Measured
Direct answer: no validated universal human detection time has been published for TB-500. The clearest post-administration study used two horses and measured the parent peptide plus metabolites in plasma and urine by LC-MS. Parent plasma concentrations became unquantifiable between 6 and 10 hours, while different metabolites and matrices produced different windows. Rat and in-vitro findings cannot be converted into a human testing timetable.
Detection time is not one property
A detection result depends on at least five variables: the analyte, species, specimen, sampling schedule, and method threshold. “TB-500 detected” may mean intact N-acetylated LKKTETQ, a shorter C-terminal metabolite, or both. Plasma and urine can also yield different profiles.
The 2012 equine LC-MS study developed a method for N-acetylated LKKTETQ and its metabolites. It reported method confirmation limits of 0.02 ng/mL in equine plasma and 0.01 ng/mL in equine urine and then applied the method to samples from horses after one exposure. These are analytical limits in specified matrices—not a human detection window.
What each study actually measured
The evidence table keeps parent peptide, metabolites, species, and endpoints separate. This prevents a longer-lived metabolite signal from being reported as persistence of intact TB-500.
| Evidence record | Model and specimen | Analyte and result | What cannot be inferred |
|---|---|---|---|
| Ho et al., 2012 | Two thoroughbred geldings; plasma and urine after one subcutaneous exposure | Parent and C-terminal metabolites confirmed by LC-MS; parent plasma signal peaked at 1–2 hours and became unquantifiable between 6 and 10 hours | Human clearance, a population detection window, or biological-effect duration |
| FDA 2026 evidence review | Regulatory synthesis of the equine record | Parent, stereoisomer, and selected metabolites documented at approximately 2 hours in plasma and 6 hours in urine | That every laboratory, specimen, or formulation has the same window |
| Rahaman et al., 2024 | Rats and in-vitro human/equine enzyme systems | Sequentially shortened metabolites; Ac-LKK remained detectable in rat urine through 72 hours | Human post-administration detection or persistence of intact parent peptide |
| WADA metabolism project | Human serum, microsomes, S9 fractions, and analytical reference work | In-vitro/ex-vivo metabolite pathways and candidate markers | An administered-human pharmacokinetic result |
FDA's TB-500 evidence review supplies the 1–2-hour peak and 6–10-hour unquantifiable summary for parent peptide in horses. The 2024 metabolism and metabolite study reports longer detection of selected rat urinary metabolites. WADA's metabolism research record describes human biological matrices used outside an administered-human trial.
Why detection, quantification, and half-life differ
Detection means a signal meets identification criteria. Quantification means the signal is above a validated numerical threshold. Half-life is a model-derived pharmacokinetic parameter requiring concentration-time data and an appropriate model. A substance can become unquantifiable while still generating detectable metabolites, so none of these terms is interchangeable.
The TB-500 half-life article explains why the equine observation does not establish a human half-life. The TB-500 mechanism evidence map also separates the seven-residue fragment from full-length thymosin beta-4. For identity context, see TB-500 vs thymosin beta-4.
Researchers can inspect the TB-500 research material, the broader recovery peptide collection, and lot documents in the NEXTWAVE PEPTIDES COA library. Lot documentation cannot create a human detection window that has not been studied.
Research limitations
The principal post-administration record involved two horses, one exposure design, and specific LC-MS methods. The rat work used a different species, route, dose, and metabolite profile. In-vitro human matrices describe biochemical processing rather than whole-body disposition. This article provides no testing-evasion advice and does not estimate an individual result.
Frequently asked questions
How long is intact TB-500 detectable in humans?
Published administered-human data were not identified in the cited records, so a validated human window cannot be stated.
Does the 72-hour rat result mean TB-500 lasts 72 hours?
No. It concerned a selected urinary metabolite in rats, not necessarily intact parent peptide and not humans.
Is detection time the same as half-life?
No. Detection depends on specimen, analyte, method, and threshold. Half-life is a pharmacokinetic parameter estimated from concentration-time data.